Latest Posts
About This Stock
More About This Stock
Read
Read
CytomX Long Term Returns Uncertain
Article By:
Don Dion
Tuesday, October 6, 2015 12:00 PM EDT
CTMX is the largest biotech this week to debut; investors could buy in at higher rates than slightly lower profile firms. CTMX has impressive partnerships with big pharma and is backed by Third Rock Ventures, Fidelity and Pfizer.
In this article: AZN, GSK, MRK, NVS, PFE, ROG, SNY, VRX, IDRA, IMGN, NLNK, SGEN, CELG, JUNO, KITE, BLUE, BLCM, ACRS
Free Cash Yield Vs. Earnings Yield To Rank Magic Formula Stocks
Article By:
Steve Alexander
Thursday, June 11, 2015 7:12 AM EDT
Most value investors will tell you that free cash flow is the purest measure of a company's success. The purpose of a business is to use assets to generate cash.